Literature DB >> 17484281

Development and evaluation of a buccal bioadhesive system for smoking cessation therapy.

S Garg1, G Kumar.   

Abstract

The objective of the present study was to develop a bilayered buccal bioadhesive film formulation of nicotine hydrogen tartrate for smoking cessation therapy, comprising a bioadhesive drug layer and a backing layer, which releases the drug at a pre-determined rate for a period of 4 h. Formulations were prepared using various bioadhesive polymers and were evaluated for physical parameters like peelability, flexibility, softness, bioadhesive strength, tensile strength, dispersion time and pharmaceutical parameters such as thickness, swelling, content uniformity, water vapour permeability and drug release. Based on these parameters formulation N2, containing hydroxypropyl methylcellulose and polycarbophil as the bioadhesive polymers, was selected as the optimized formulation. The formulation showed suitable adhesion and an initial burst release of 40% drug in first 15 min followed by a total 80% drug release in a characteristic manner until 4 h; which is the desired time of application. This release pattern is beneficial for patients suffering from emergent cravings. Backing layers of the films were studied by a moisture vapor permeability test and it was observed that the percentage of moisture which permeated through single layered films was much higher than through bilayered films implying that a backing layer would prevent washing out of drug by the saliva.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484281

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Development and evaluation of buccoadhesive controlled release tablets of lercanidipine.

Authors:  Shrikant Charde; Madri Mudgal; Lajwinder Kumar; Ranendra Saha
Journal:  AAPS PharmSciTech       Date:  2008-01-30       Impact factor: 3.246

2.  Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.

Authors:  Tiantian Gong; Wei Zhang; Michael A Parniak; Phillip W Graebing; Bernard Moncla; Phalguni Gupta; Kerry M Empey; Lisa C Rohan
Journal:  J Pharm Innov       Date:  2017-03-03       Impact factor: 2.750

3.  Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles.

Authors:  Pakorn Kraisit; Sontaya Limmatvapirat; Manee Luangtana-Anan; Pornsak Sriamornsak
Journal:  Asian J Pharm Sci       Date:  2017-07-24       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.